Cardiol Therapeutics
CRDL • NASDAQ • Stock Fundamentals
Cardiol Therapeutics is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO David G. Elsley, with a market cap of $149.9M.
Market Cap$149.9M
Employees17.0
CEODavid G. Elsley
CountryCanada
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Cardiol Therapeutics FAQ
Common questions about Cardiol Therapeutics
Cardiol Therapeutics (CRDL) has a market capitalization of $149.9M and trades on NASDAQ.
Cardiol Therapeutics has approximately 17 employees.